Effect of bisphosphonates on pain and quality of life in patients with bone metastases

This publication has 92 references indexed in Scilit:

• Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden
  International Journal Of Clinical Practice, 2007
• The last 3 days of life in three different care settings in The Netherlands
  Supportive Care in Cancer, 2007
• Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study
  Supportive Care in Cancer, 2007
• Final development and validation of the BOMET-QoL questionnaire for assessing quality of life in patients with malignant bone disease due to neoplasia
  Journal of Medical Economics, 2007
• The use of bisphosphonates in palliative treatment of bone metastases in a terminally ill, oncological elderly population
  Archives of Gerontology and Geriatrics, 2006
• Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain
  Journal of Clinical Oncology, 2003
• Transient relief of metastatic cancer bone pain by oral administration of etidronate
  Journal of Bone and Mineral Metabolism, 2002
• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  JNCI Journal of the National Cancer Institute, 1993
• EuroQol - a new facility for the measurement of health-related quality of life
  Health Policy, 1990
• Measuring the quality of life of cancer patients
  Journal of Chronic Diseases, 1981